National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 21200 [2023-07403]

Download as PDF 21200 Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices technology to minimize the information collection burden. DEPARTMENT OF HEALTH AND HUMAN SERVICES Maria G. Button, Director, Executive Secretariat. National Institutes of Health [FR Doc. 2023–07410 Filed 4–7–23; 8:45 am] National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Populationbased Research in Vector-borne Disease. Date: April 17, 2023. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 257– 2638, steeleln@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 4, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07404 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:13 Apr 07, 2023 Jkt 259001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIAMS. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIAMS. Date: May 2–3, 2023. Closed: May 02, 2023, 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 620/630, 35 Convent Drive, Bethesda, MD 20892. Closed: May 03, 2023, 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 620/630, 35 Convent Drive, Bethesda, MD 20892. Contact Person: John J. O’Shea, MD, Scientific Director of Intramural Research, National Institute of Arthritis & Musculoskeletal and Skin Diseases, Building 10, Bethesda, MD 20892, (301) 496–2612, osheaj@mail.nih.gov. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19- PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 safety-plan/Pages/default.aspx and the NIH testing and assessment web page at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/ visitor-testing-requirement.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID–19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https://www.saferfederal workforce.gov/faq/visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/ dohs/safety/NIH-covid-19-safety-plan/ COVID-assessment-testing/Pages/personsafter-exposure.aspx and What Happens When Someone Tests Positive at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/ test-positive.aspx. Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: April 4, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07403 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Alcohol Abuse and Alcoholism. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov/). A portion of this meeting will be closed to the public in accordance with E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Page 21200]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07403]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NIAMS.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the NATIONAL 
INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIAMS.
    Date: May 2-3, 2023.
    Closed: May 02, 2023, 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: Porter Neuroscience Research Center, Building 35A, 620/
630, 35 Convent Drive, Bethesda, MD 20892.
    Closed: May 03, 2023, 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: Porter Neuroscience Research Center, Building 35A, 620/
630, 35 Convent Drive, Bethesda, MD 20892.
    Contact Person: John J. O'Shea, MD, Scientific Director of 
Intramural Research, National Institute of Arthritis & 
Musculoskeletal and Skin Diseases, Building 10, Bethesda, MD 20892, 
(301) 496-2612, [email protected].

    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Additional Health and Safety Guidance: Before attending a 
meeting at an NIH facility, it is important that visitors review the 
NIH COVID-19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx and the NIH testing and 
assessment web page at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/visitor-testing-requirement.aspx for information about requirements and procedures 
for entering NIH facilities, especially when COVID-19 community 
levels are medium or high. In addition, the Safer Federal Workforce 
website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an 
individual has a COVID-19 diagnosis within 10 days of the meeting, 
that person must attend virtually. (For more information please read 
NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What 
Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx. Anyone from the public can attend the open 
portion of the meeting virtually via the NIH Videocasting website 
(https://videocast.nih.gov). Please continue checking these websites, 
in addition to the committee website listed below, for the most up 
to date guidance as the meeting date approaches.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: April 4, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07403 Filed 4-7-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.